Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Can MRI predict which patients are most likely to benefit from percutaneous positioning of volume-adjustable balloon devices?
Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review.
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: Mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures.
Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.
Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell. 2017 08; 16(4):837-846.
View in:
PubMed
subject areas
Animals
beta-Galactosidase
Caenorhabditis elegans
Caenorhabditis elegans Proteins
Catalase
Cells, Cultured
Cellular Senescence
Cyclin-Dependent Kinase Inhibitor p16
Diabetes Mellitus, Experimental
Endothelial Progenitor Cells
Genistein
Humans
Male
Mice
MicroRNAs
NADPH Oxidases
Nitric Oxide Synthase Type III
Plasminogen Activator Inhibitor 1
Serpins
Sirtuin 1
Sirtuins
Streptozocin
Superoxides
Telomerase
Tumor Necrosis Factor-alpha
authors with profiles
Eugene Chang